Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Androgenetic alopecia treatments are becoming more personalized and include new therapies like topical antiandrogens and regenerative strategies.

Better standardization and transparency in statistical reporting are needed to improve hair care research quality.

Herbal treatments are gaining interest as alternatives for hair loss.

SFRP2 and PTGDS may be key factors in female hair loss.

Innate lymphoid cells help us understand and manage allergic diseases better.

Sulfotransferase SULT1A1 activity may predict minoxidil treatment success for hair loss.

Early treatment of Female Pattern Hair Loss is important to stop it from getting worse, and various treatments can help, especially in mild to moderate cases.

PDE inhibitors, especially PDE4 inhibitors like apremilast, are effective for certain inflammatory skin conditions but have side effects and can be costly.

Vepdegestrant may become the first FDA-approved PROTAC degrader, marking a new era in drug development.

TRIV-509 quickly improves skin barrier and cell health in atopic dermatitis.

CP-690,550 significantly reduced itching in patients with moderate-to-severe plaque psoriasis.

PEVIII is a promising treatment for Pseudomonas aeruginosa keratitis.

Epristeride's metabolism involves key metabolites and proteins, affecting its use in doping tests.

Epristeride's metabolism in zebrafish helps improve doping detection methods.

ATR12-351 ointment safely delivers LEKTI protein to the skin, reducing enzyme activity in Netherton syndrome.

Upadacitinib effectively treats psoriasis and lichen planus together.

PH-762 shows promise in treating skin cancer by effectively targeting and silencing PD-1 in tumors with minimal side effects.

New itaconate prodrugs improve its absorption and effectiveness for treating inflammation.

PROTACs have become a breakthrough in medicine by effectively targeting and degrading specific proteins to treat diseases.

PRIDE syndrome helps identify skin side effects from EGFR inhibitors like erlotinib.

Triptolide effectively and safely reduces actinic keratosis lesions in mice.

A new anti-baldness patch effectively treats hair loss by blocking enzymes linked to the condition.

Adiantum capillus extract reduces pain and swelling in animals.

Using finasteride with TIP extends time off period for prostate cancer patients.

ATR04-484 ointment shows promise for treating skin issues from cancer therapies.

Upadacitinib may effectively treat resistant lichen planopilaris.

SIG-1451 could be a promising new treatment for atopic dermatitis.

Hit15 shows promise as a COVID-19 treatment by reducing virus infection and inflammation.

Apremilast improved symptoms in patients with severe skin conditions.

The drug IPI-926 is safe at 160 mg daily and may help treat certain tumors, especially basal cell carcinoma.